Danielle Boyle: Collaboration Across Borders Is Helping Shape the Future of ITP Care
Danielle Boyle, Founder and CEO of ITP Australia and New Zealand, reposted from ITP Support Association on LinkedIn:
”One of the greatest privileges of being part of the International ITP Alliance is the opportunity to connect and collaborate with incredible people from around the world who are committed to improving the lives of ITP patients every single day.
Congratulations to Mervyn Morgan, the ITP Support Association team, and their Medical Advisors on an outstanding few days of intensive planning, meaningful discussion, collaboration, and learning.
It was a real privilege to attend, contribute, and learn alongside so many passionate and dedicated individuals.
Thank you for all that you do for the ITP community.
Your commitment continues to make a genuine difference.
Keep up the amazing work!”
Quoting ITP Support Association‘s post:
”Thank You for an Incredible 2026 Annual Patient Convention!
What a truly phenomenal day!
We want to say a heartfelt thank you to everyone who joined us this past weekend at the Royal College of Pathologists (RCPath) in London for our Annual Patient Convention.
Did you attend this year?
We would really appreciate your feedback to help us shape future events!
Please take a few moments to fill out our convention survey.
Bringing our community together in person is always the highlight of our year, and this event was made unforgettable by the incredible people who contributed their time, expertise, and support.
We want to extend our deepest gratitude to:
Our Expert Speakers and Researchers: A huge thank you to Professor Adrian Newland , Professor David Kuter, Dr Cindy Neunert, Dr John Grainger, Dr Guillaume Moulis, Dr Catherine Bagot, Professor Nichola Cooper, Dr Fred Chen, Dr Alice Hart, and Dr Drew Provan.
Our Lead Organisers: Our immense appreciation to ITPSA CEO Mervyn Morgan and ITP Australia and New Zealand CEO Danielle Boyle for their tireless work in bringing this collaboration to life.
The ITP Board Members: Thank you for your continued leadership, dedication, and guidance behind the scenes.
Our Incredible Sponsors: This vital day would not have been possible without the generous support of our Platinum Sponsor, Argenx, our Gold Sponsors, Sanofi and Sobi – Swedish Orphan Biovitrum AB (publ), and our Bronze Sponsors, Novartis , Amgen , and Fortrea.
Our Event Team and Partners: A brilliant team effort from ITP Australia and New Zealand, Events@No6, Royal College of Pathologists (RCPath), Iris Web Media Lucy Standbridge, Lyndsey Challis Photography, and The Lion Press.
Our Wonderful Attendees: To every single patient, caregiver, family member, healthcare professional, and colleague who travelled to be there: thank you for your questions, your openness, and your continued dedication to supporting one another.
We are also thrilled by the wonderful response to the official launch of our two brand new books, Living With ITP and Pregnancy in ITP!
If you did not manage to grab a physical copy on the day, remember you can always view the digital versions on our website.”

Stay updated with Hemostasis Today.
-
Aug 21, 2026, 21:58Toby Richards: WEHI Trial Solidifies IV Iron as Third-Trimester Standard
-
Aug 21, 2026, 21:51Mehak Trehan: From Reading the Chapter to Writing One
-
Aug 21, 2026, 21:38Ann Reilly: Navigating Postoperative vs. Acute Blood Loss Anemia – A CDI Case Study
-
Aug 21, 2026, 21:29Merlin Crossley: Atomic Precision in Sickle Cell Care – Structural Targeting for Fetal Globin Reactivation
-
Aug 21, 2026, 19:09Aphisit Thongthaisin: Admitted to Sorbonne University’s T2H University Diploma for 2026/2027
-
Aug 21, 2026, 19:07José Luis Ferreiro Gutiérrez: Proud to Be Elected Chairperson-Elect of the ESC Working Group on Thrombosis
-
Aug 21, 2026, 19:00Manuel Monreal: New RIETE Registry Data on VTE Recurrence and Bleeding During Anticoagulation
-
Aug 21, 2026, 18:39Ronak H. Mistry: Updated ASH ITP Guidelines Bring New Guidance for Managing ITP
-
Aug 21, 2026, 18:22Ahmed Bennis: NOAC Use Is Associated With Slower Cognitive Decline in AF and Alzheimer’s Disease